TAGline: Intellectual Property and Access

TAGline (Fall 2018)

As the Trump administration makes noise about the high price of pharmaceuticals while doubling down on its commitment to “protect the engine of American ingenuity,” this issue of TAGline dives deep into the rhetoric and realities of intellectual property  (IP)  protections. 

It also looks at  the current wave of political shenanigans on critical drugs, surfacing the fundamental lies and vested interests that deny medication to those in need in the United States and around the world. (PDF)

Links to other websites are current at date of posting but not maintained.